EP-1913: National automated collection of standardised and population-based radiation therapy data in Sweden  by Nyholm, T. et al.
ESTRO 35 2016                                                                                                                                                    S907 
________________________________________________________________________________ 
and simultaneously sparing the surrounding normal 
structures. Nevertheless, in order to decrease the growth of 
cancerous cells, a high dose of ionizing radiation is needed 
which would generally cause the side effects on healthy 
organs. The use of nanotechnology in cancer treatment offers 
some exciting possibilities including destroying cancer tumors 
with minimal damage to healthy tissues. Zinc Oxide 
nanoparticles (ZnO NPs) are wide band gap semiconductors 
and seem to have a good effect on increasing the absorbed 
dose of target volume especially when doped with a high Z 
element. The aim of this study is to evaluate the effect of 
ZnO NPs doped with Gadolinium on dose enhancement factor 
at different concentrations irradiating by 6MV photon beams.  
 
Material and Methods: In order to study the influence of this 
NP on dose enhancement, PRESAGE dosimeter was fabricated 
by the reported procedure and calibrated against ionization 
chamber, delivering certain levels of absorbed doses. Then 
various concentrations of ZnO NPs and also ZnO NPs doped 
with 5% Gd were incorporated in to PRESAGE composition and 
irradiated by 6 MV photon beams. By using a UV-Vis 
spectrophotometer, optical density changes and also dose 
enhancement factor (DEF) were determined. 
 
Results: Figure 1 shows the color changes of PRESAGE 
containing various concentrations of NPs. 
 
 
 
Fig1. PRESAGE filled cuvettes with and without NPs at dose of 
10Gy. 1) PRESAGE without NPs. 2) PRESAGE with 20µg/ml ZnO 
NPs doped with %5 Gd. 3) PRESAGE with 4000µg/ml ZnO NPs 
doped with %5 Gd. 4) PRESAGE with 4000µg/ml ZnO NPs. 
Table 1 shows DEF acquired by various concentrations of NPs. 
Table 1. DEF of various concentrations of NPs. 
 
 
 
Conclusion: The results of this study revealed that ZnO NPs 
doped with Gd are new proposing substances for enhancing 
the absorbed dose and increasing the therapeutic ratio even 
in high energy photon beams. Various reasons may cause the 
DEF for 6MV photon beams such as photoelectric effect for 
low energy photon beams in continues X-ray spectrum, 
attenuated photons or pair production effect. Using these 
NPs not only reduces the needed MU to deliver a certain 
amount of absorbed dose, but also can lead to great succeeds 
in reducing treatment time. The concentration of NPs has a 
direct relation with DEF. 
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Purpose or Objective: Photodynamic therapy (PDT) is an 
effective treatment modality for specific superficial tumors, 
which uses laser light to activate photosensitizers that have 
been selectively absorbed by tumor cells. However, the finite 
penetration depth of laser light has limited clinical 
applications of PDT. This work investigates the outcomes of 
using Cerenkov light emission from 45MV photon beams on a 
LA45 accelerator to activate photosensitizers for cancer 
therapy. We named this new treatment technique as Radio-
dynamic therapy (RDT). 
 
Material and Methods: Firstly, Monte Carlo simulations were 
utilized to simulate various energies of Cerenkov light and its 
spectroscopy in excited target areas and their efficiency for 
photosensitizer activation. Then, the inner excitation 
efficiency from Cerenkov light in RDT theoretically compared 
with the efficiency of exotic excitation from the external 
laser light in PDT. In addition, we also tested the difference 
of excitation efficiency between a patented catalyst 
coenzyme was added as a substrate and without the 
coenzyme. Next, utilize a specific probe of DMA (Singlet O2 
fluorescent probe-9, 10-dimethylanthracene) to detect 
singlet oxygen. Finally, we also compared our results with 
previous experimental results that reported in previous 
literatures.  
 
Results: Our Monte Carlo results showed that the Cerenkov 
light intensity induced at 45MV photon beams on a LA45 is 8 - 
10 times of the Cerenkov light intensity induced at 6MV beam 
on a conventional accelerator. In RDT, excitation efficiency 
to photosensitizers at 400-450nm peaked wavelength (Soret 
Band) equals 20 times of laser light at 630nm in PDT. The 
homogenous inner excitation in RDT is also about 20 times 
(continuous spectrum excitation and inner scattering) of the 
exotic excitation and exponential attenuation laser light in 
the target of using PDT. Furthermore, the patented catalyst 
coenzyme enhanced the excitation efficiency of 
photosensitizers by 3-6 times under different conditions. In 
clinical situation, the new technique RDT also showed 
favorable outcomes for early and late stage of specific 
cancers and it also good at metastatic cancers treatment. 
 
Conclusion: Our results indicated that the process of using 
the Cerenkov light emission from 45MV photon beams to 
excite photosensitizers has similar process and efficiency as 
conventional laser in PDT. Compared these advantages with 
conventional PDT, RDT may be developed into a potential 
treatment modality for cancer of various stages and other 
diseases.  
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Purpose or Objective: To develop an infrastructure for 
structured and automated collection of interoperable 
radiation therapy (RT) data into a Swedish national quality 
register. 
 
Material and Methods: The present study was initiated in 
2012 with the participation of seven of the 15 Swedish clinics 
delivering radiation therapy. A national RT nomenclature and 
a database for structured unified storage of RT data at each 
clinic (Medical Information Quality Archive; MIQA) have been 
developed. Aggregated data from the MIQA databases are 
sent to a Swedish national RT register located on the same IT 
framework (INCA) as the national diagnosis-specific quality 
registries. 
 
Results: The suggested naming convention has to date been 
integrated into the clinical workflow at 12 sites and MIQA is 
installed at six of these. Involvement of the remaining 
Swedish RT clinics is ongoing, and they are expected to be 
part of the infrastructure by 2016. RT data collection from 
Aria®, Mosaiq®, Eclipse™, and Oncentra® is supported. 
Manual curation of RT-structure information is needed for 
approximately 10% of target volumes, but rarely for normal 
tissue structures, demonstrating a good compliance to the RT 
nomenclature. Aggregated dose/volume descriptors are 
calculated based on the information in MIQA and sent to INCA 
using a dedicated service (MIQA2INCA). Correct linkage of 
data for each patient to the diagnosis-specific quality 
registries on the INCA platform is assured by the unique 
Swedish personal identity number. 
 
Conclusion: An infrastructure for structured and automated 
prospective collection of syntactically interoperable radiation 
therapy data into a national register for RT data in Sweden 
has been implemented. Future developments include 
adapting MIQA to other treatment modalities (e.g. proton 
therapy and brachytherapy) and finding strategies to 
harmonize structure delineations. 
The database is built on the same platform as used by the 
diagnos specific quality registers in Sweden hosting 
information about additional treatments, clinical and patient 
reported outcomes. 
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Purpose or Objective: Modern radiotherapy routinely 
involves the use of small radiation fields, either for the 
delivery of stereotactic treatments, or as components of 
intensity-modulated radiation therapy (IMRT). The purpose of 
the small field dose rate dependence audit is to check 
dosimetric data in the treatment planning system (TPS), as 
used for patient Intensity Modulated Radiation Therapy 
(IMRT) treatments, related to a radiotherapy treatment unit 
equipped with an MLC. 
 
Material and Methods: The methodology worked out in the 
framework of the IAEA Coordinated Research Project 
E2.40.18 was used. The audit participants were asked to 
calculate the number of MUs for 5 MLC-shaped field sizes 
(10×10 cm2, 6×6 cm2, 4×4 cm2, 3×3 cm2 and 2×2 cm2) to 
deliver 10 Gy on axis at 10 cm depth, 100 cm SSD in water, 
using their treatment planning system. These calculations 
had to be repeated for each photon beam energy used for 
IMRT treatments. Eventually, they had to calculate the dose 
rate (Gy/MU) for each of the five MLC defined field sizes and 
normalize each value to the 10×10 cm2 value. These results 
were compared with the benchmark data from the 
publication: "The Radiological Physics Center’s standard 
dataset for small field size output factors" (Followill et al., 
Journal of Applied Clinical Medical Physics, 2012). Since this 
dataset did not provide data for certain beam qualities the 
interpolation/extrapolation was performed fitting the second 
degree polynomials to the RPC measured values. 
Results: The audit was performed in 32 (out of 35) Polish 
radiotherapy centres for different linacs, TPS, MLC types and 
beam energies. The beam qualities ranged from 4 MV to 20 
MV. In total, 81 beams were checked (Varian 41, Elekta 24, 
Siemens 16). When compared to the treatment planning 
system-calculated mean output factors, the RPC’s mean 
measured values agreed for all field sizes and energies within 
1% difference for Elekta machines. For Varian machines the 
difference exceeded 1% for 3×3 cm2 and 2×2 cm2 fields for 6 
MV beams (1.6% and 2.3%). For Siemens machines the 
differences exceeded 1% for 2×2 cm2 fields for both beam 
qualities 6 MV and 15 MV (1.6% and 1.7%). 
 
Conclusion: The RPC’s measured values provide a consistent 
dataset for small field output factors that can be used as a 
redundant QA check of a treatment planning system 
dosimetry data for small-field treatments. The RPC’s 
measured values have a small uncertainty (standard deviation 
< 2%), while the values calculated from the various planning 
systems and their beam models had a greater uncertainty, 
especially for the smallest field sizes. Such QA dataset 
against which the institution can compare its measured or 
calculated values is helpful to ensure accurate IMRT dose 
delivery by identifying discrepancies prior to any patients 
being treated. Any discrepancies noted between the standard 
dataset and calculated values should be investigated with 
careful measurements and with attention to the specific 
beam model. 
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Purpose or Objective: The medical linear accelerator(LINAC) 
is the most widely used in the modern radiation therapy. 
Recently, advanced radiation therapy technique require a 
high precision of the LINAC. Therefore, more precise quality 
assurance(QA) of the LINAC is required. In this study, we 
developed QA system using a video image for mechanical QA 
of LINAC. The our QA system may measure the mechanical 
isocenter offset(gantry, collimator, couch) and the couch 
movement. The purpose of this study was: ⓐthe 
Simplification of mechanical QA procedures, ⓑthe 
quantification of the measurement results, ⓒthe 
improvement of the measurement accuracy by eliminating 
the observers dependence. 
 
Material and Methods: The our QA system developed in this 
study use a method of analysis based on the recorded image 
by camera(Figure 1). Our QA system has configured the 
hardware into three parts. The first, it is a indicating unit 
pointing to the isocenter. The second, it is a recording unit 
for recording an image. Finally, the third, it is an analysis 
unit for analyzing the image. For the accuracy evaluation of 
the our QA system, we performed the two experiments. The 
first, it is the mechanical isocenter offset check for rotation 
of gantry and collimator. We measured the mechanical 
isocenter, and evaluated for the accuracy of the 
measurement about intentional offset distances(±1mm, 
±2mm). The second, it is couch movement check(direction of 
X, Y and Z). We compared the measured results by our QA 
system and the movement values shown in the R&V. 
 
